Li Qian, Lu Yun, Wang Ya-Fei, Liu Xu-Ping, Qi Jun-Yuan, Zou De-Hui, Zhao Yao-Zhong, Qiu Lu-Gui
Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.
Zhonghua Yi Xue Za Zhi. 2009 Jul 28;89(28):1979-82.
To summarize the clinical significance and 13q- characters of 100 multiple myeloma (MM) patients detected by interphase fluorescence in situ hybridization (i-FISH).
Specimens of bone marrow were collected from 100 patients with MM who visited the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences in Tianjin, China. Chromosome R-banding analysis and i-FISH were conducted.
(1) i-FISH was used to investigate 100 patients with MM, whose median age was 56 years and 19 (19.0%) cases showed chromosome 13q deletions/monosony13 (Delta13); conventional cytogenetics (CC) revealed informative MM karyotypes in 24 patients (24.0%),with Delta13 in 10 (10.0%) of them. Detection rate of the two methods had no significant difference (P = 0.053), but in newly diagnosed patients i-FISH was much more sensitive than CC test (Detection rate, 25.3% vs 9.3%, P = 0.008). (2) Among the whole cases, 93 of them had complete follow-up information. The overall survival (OS) of the 93 patients was 41 (1-69) months. Univariate analysis showed that the positive rate of Delta13 detected by i-FISH >50%, clonal chromosome 13 abnormality (C13A), nonhyperdiploidy, Delta13 detected by both CC and i-FISH, beta2-MG > or = 3.5 mg/L were associated with significantly shorter OS. Multivariate analysis indicated that the positive rate of Delta13 detected by i-FISH > 50% and beta2-MG > or = 3.5 mg/L were the independent unfavorable factors. (3) According to the two independent unfavorable factors mentioned above, we divided the 93 patients into three groups: low-risk, standard-risk and high-risk. And there were significant differences of OS among the 3 groups (P < 0.05).
(1) FISH studies demonstrate a high sensitivity at detecting chromosome 13 abnormality and should be used in the routine evaluation of MM. (2) The positive rate of Delta13 detected by i-FISH > 50% and beta2-MG > or = 3.5 mg/L were the independent adverse prognostic factors.
总结100例采用间期荧光原位杂交(i-FISH)检测的多发性骨髓瘤(MM)患者的临床意义及13q-特征。
收集中国医学科学院血液病医院(天津)100例MM患者的骨髓标本,进行染色体R显带分析和i-FISH检测。
(1)应用i-FISH检测100例MM患者,中位年龄56岁,19例(19.0%)出现13号染色体缺失/13号染色体单体(Delta13);常规细胞遗传学(CC)在24例患者(24.0%)中检测到有意义的MM核型,其中10例(10.0%)出现Delta13。两种方法的检出率无显著差异(P = 0.053),但在新诊断患者中,i-FISH比CC检测更敏感(检出率分别为25.3%和9.3%,P = 0.008)。(2)全部病例中,93例有完整随访资料。93例患者的总生存期(OS)为41(1-69)个月。单因素分析显示,i-FISH检测Delta13阳性率>50%、克隆性13号染色体异常(C13A)、非超二倍体、CC和i-FISH均检测到Delta13、β2-微球蛋白>或=3.5 mg/L与OS显著缩短相关。多因素分析表明,i-FISH检测Delta13阳性率>50%和β2-微球蛋白>或=3.5 mg/L是独立的不良因素。(3)根据上述两个独立的不良因素,将93例患者分为低危、中危和高危三组。三组患者的OS有显著差异(P < 0.05)。
(1)FISH研究在检测13号染色体异常方面具有高敏感性,应常规应用于MM的评估。(2)i-FISH检测Delta13阳性率>50%和β2-微球蛋白>或=3.5 mg/L是独立的不良预后因素。